Trial intelligence / Profile preview

Steroid injection versus night splint for carpal tunnel syndrome

ISRCTN09392969Phase 4Completed

Sponsor
University of Keele (UK)
Start
Apr 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01

Overview

Phase 4, randomised, open-label trial of methylprednisolone in carpal tunnel syndrome (CTS) (2 arms), sponsored by University of Keele (UK). Primary endpoints: Boston Carpal Tunnel Questionnaire symptom severity at 24 months and Boston Carpal Tunnel Questionnaire functional status at 24 months. Started Apr 2014; status: completed.

02

Drugs

methylprednisolone
03

Conditions

carpal tunnel syndrome (CTS)

Beyond the preview

Go deeper on ISRCTN09392969.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN09392969.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call